Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

This study has been completed.
Sponsor:
Collaborator:
ANZICS Clinical Trials Group
Information provided by:
The George Institute
ClinicalTrials.gov Identifier:
NCT00221013
First received: September 14, 2005
Last updated: February 25, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
No publications provided by The George Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):